Mezigdomide (CC-92480), a Novel Cereblon E3 Ligase Modulator, Induces Vulnerability of Multiple Myeloma Cells to T-Cell-Mediated Killing
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:7108-7109 - Subject
- Language
- ISSN
- 0006-4971